Turn Therapeutics (TTRX) Change in Accured Expenses (2024 - 2026)
Turn Therapeutics' quarterly Change in Accured Expenses came in at -$613464.0 in Q1 2026, down 2853.75% year-on-year from $22277.4 in Q1 2025, and down 192.35% quarter-over-quarter from $664303.0 in Q4 2025.
Turn Therapeutics has reported Change in Accured Expenses for 3 years, with the latest figure at -$613464.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 2853.75% year-over-year to -$613464.0; the trailing twelve-month figure through Mar 2026 stood at $80654.0 (changed N/A YoY), and the FY2025 full-year result was $2.3 million, up 1015.95% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$613464.0, down from $664303.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $664303.0 in Q4 2025, with the low at -$613464.0 in Q1 2026.
- Average Change in Accured Expenses over 3 years is $20163.5, with a median of $14907.5 recorded in 2024.
- Year-over-year, Change in Accured Expenses jumped 1213.27% in 2025 and tumbled 2853.75% in 2026.
- Tracing TTRX's Change in Accured Expenses over 3 years: stood at $50584.0 in 2024, then jumped by 1213.27% to $664303.0 in 2025, then slumped by 192.35% to -$613464.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$613464.0 (Q1 2026), $664303.0 (Q4 2025), and -$20769.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | -613,464.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -613,464.00 |
| Mar 31, 2026 | -613,464.00 |
| Dec 31, 2025 | 664,303.00 |
| Dec 31, 2025 | 664,303.00 |
| Mar 31, 2025 | -20,769.00 |
| Mar 31, 2025 | -20,769.00 |
| Dec 31, 2024 | 50,584.00 |
| Dec 31, 2024 | 50,584.00 |